<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-14T06:01:56Z</responseDate>
  <request identifier="oai:figshare.com:article/34018382" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/34018382</identifier>
        <datestamp>2026-09-28T20:01:20Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_15</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_1</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;The inverted pyramid of care.&lt;/p&gt;</dc:title>
          <dc:creator>Laura A. Magee (8788637)</dc:creator>
          <dc:creator>Peter von Dadelszen (258508)</dc:creator>
          <dc:creator>Kypros H. Nicolaides (10058014)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Neuroscience</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>provide updated guidance</dc:subject>
          <dc:subject>policy forum advocates</dc:subject>
          <dc:subject>placenta accreta spectrum</dc:subject>
          <dc:subject>advancing gestational age</dc:subject>
          <dc:subject>pregnancy complications occur</dc:subject>
          <dc:subject>structured risk assessment</dc:subject>
          <dc:subject>div &gt;&lt; p</dc:subject>
          <dc:subject>inverted &amp;# 8217</dc:subject>
          <dc:subject>improve antenatal care</dc:subject>
          <dc:subject>care &amp;# 8217</dc:subject>
          <dc:subject>antenatal care</dc:subject>
          <dc:subject>early pregnancy</dc:subject>
          <dc:subject>&amp;# 8216</dc:subject>
          <dc:subject>inverted pyramid</dc:subject>
          <dc:subject>increased risk</dc:subject>
          <dc:subject>building risk</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>uteroplacental problems</dc:subject>
          <dc:subject>personalised surveillance</dc:subject>
          <dc:subject>intrinsic fetal</dc:subject>
          <dc:subject>including development</dc:subject>
          <dc:subject>enhanced surveillance</dc:subject>
          <dc:subject>chromosomal abnormalities</dc:subject>
          <dc:subject>become clear</dc:subject>
          <dc:subject>artificial intelligence</dc:subject>
          <dc:subject>accurate methods</dc:subject>
          <dc:subject>accelerating frequency</dc:subject>
          <dc:description>&lt;p&gt;This inverted pyramid of care proposes a focus on the first, rather than the third, trimester of pregnancy. The concept emphasises that many pregnancy complications can be predicted in early pregnancy, by combining maternal history, blood pressure and other biophysical measurements, and biochemical testing. CRM, cardio-renal-metabolic; GDM, gestational diabetes mellitus; LGA, large-for-gestational age; PET, pre-eclampsia; PTB, preterm birth; SGA, small-for-gestational age. * The diagnosis of GDM is usually made at 24–28 weeks’ gestation, by oral glucose tolerance testing.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-28T20:01:17Z</dc:date>
          <dc:type>Image</dc:type>
          <dc:type>Figure</dc:type>
          <dc:identifier>10.1371/journal.pmed.1005255.g001</dc:identifier>
          <dc:relation>https://figshare.com/articles/figure/_p_The_inverted_pyramid_of_care_p_/34018382</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
